This site is under construction. Please check back later.

Carnitor® is indicated for the treatment of primary systemic carnitine deficiency and for the acute and chronic treatment of inborn errors of metabolism which results in a secondary carnitine deficiency.

Adverse events reported with Carnitor® use include nausea, vomiting, body odor, gastritis and seizures. There are no reported contraindications or warnings. See Prescribing Information.

Prescribing Information for Carnitor Injection Prescribing Information for Carnitor Tablets and Oral Solution